{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:38:23Z","timestamp":1789666703441,"version":"4.0.1"},"reference-count":74,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000015","name":"U.S. Department of Energy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006227","name":"Lawrence Livermore National Laboratory","doi-asserted-by":"publisher","award":["DE-AC52-07NA27344"],"award-info":[{"award-number":["DE-AC52-07NA27344"]}],"id":[{"id":"10.13039\/100006227","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006227","name":"Lawrence Livermore National Laboratory","doi-asserted-by":"publisher","award":["LLNL-JRNL- 823245"],"award-info":[{"award-number":["LLNL-JRNL- 823245"]}],"id":[{"id":"10.13039\/100006227","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomaterials"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/j.biomaterials.2022.121378","type":"journal-article","created":{"date-parts":[[2022,1,22]],"date-time":"2022-01-22T23:26:03Z","timestamp":1642893963000},"page":"121378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"special_numbering":"C","title":["Extracellular matrix modulates T cell clearance of malignant cells in vitro"],"prefix":"10.1016","volume":"282","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3059-5135","authenticated-orcid":false,"given":"Claire","family":"Robertson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aimy","family":"Sebastian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6223-9760","authenticated-orcid":false,"given":"Aubree","family":"Hinckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1842-0495","authenticated-orcid":false,"given":"Naiomy D.","family":"Rios-Arce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3628-9486","authenticated-orcid":false,"given":"William F.","family":"Hynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2029-8962","authenticated-orcid":false,"given":"Skye A.","family":"Edwards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1605-3193","authenticated-orcid":false,"given":"Nicholas R.","family":"Hum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth K.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9546-5561","authenticated-orcid":false,"given":"Gabriela G.","family":"Loots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew A.","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica L.","family":"Moya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11","key":"10.1016\/j.biomaterials.2022.121378_bib1","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1038\/s41577-020-0306-5","article-title":"A guide to cancer immunotherapy: from T cell basic science to clinical practice","volume":"20","author":"Waldman","year":"2020","journal-title":"Nat. Rev. Immunol."},{"issue":"459","key":"10.1016\/j.biomaterials.2022.121378_bib2","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7807","article-title":"The hallmarks of successful anticancer immunotherapy","volume":"10","author":"Galluzzi","year":"2018","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121378_bib3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"6411","key":"10.1016\/j.biomaterials.2022.121378_bib4","doi-asserted-by":"crossref","DOI":"10.1126\/science.aar3593","article-title":"Pan-tumor genomic biomarkers for PD-1 checkpoint blockade-based immunotherapy","volume":"362","author":"Cristescu","year":"2018","journal-title":"Science (New York, N.Y.)"},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121378_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121378_bib6","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","article-title":"The immune landscape of cancer","volume":"48","author":"Thorsson","year":"2018","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S1470-2045(17)30904-X","article-title":"Tumour-infiltrating lymphocytes and prognosis in different subtypes of breast cancer: a pooled analysis of 3771 patients treated with neoadjuvant therapy","volume":"19","author":"Denkert","year":"2018","journal-title":"Lancet Oncol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2016.1257452","article-title":"Tumor-infiltrating lymphocyte composition, organization and PD-1\/PD-L1 expression are linked in breast cancer","volume":"6","author":"Buisseret","year":"2017","journal-title":"OncoImmunology"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121378_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abc8346","article-title":"Laminin \u03b32\u2013mediating T cell exclusion attenuates response to anti\u2013PD-1 therapy","volume":"7","author":"Li","year":"2021","journal-title":"Sci. Adv."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib10","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.yexcr.2015.11.009","article-title":"The extracellular matrix in breast cancer predicts prognosis through composition, splicing, and crosslinking","volume":"343","author":"Robertson","year":"2016","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib11","doi-asserted-by":"crossref","first-page":"4692","DOI":"10.1038\/s41467-018-06654-8","article-title":"TGF-\u03b2-associated extracellular matrix genes link cancer-associated fibroblasts to immune evasion and immunotherapy failure","volume":"9","author":"Chakravarthy","year":"2018","journal-title":"Nat. Commun."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121378_bib12","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/path.2278","article-title":"Extracellular matrix signature identifies breast cancer subgroups with different clinical outcome","volume":"214","author":"Bergamaschi","year":"2008","journal-title":"J. Pathol."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121378_bib13","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1039\/c5ib00040h","article-title":"Human breast cancer invasion and aggression correlates with ECM stiffening and immune cell infiltration","volume":"7","author":"Acerbi","year":"2015","journal-title":"Integr. Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib14","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/s41467-017-00925-6","article-title":"Galectin-3 captures interferon-gamma in the tumor matrix reducing chemokine gradient production and T-cell tumor infiltration","volume":"8","author":"Gordon-Alonso","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121378_bib15","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1074\/jbc.M311183200","article-title":"Presentation of galectin-1 by extracellular matrix triggers T cell death","volume":"279","author":"He","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121378_bib16","doi-asserted-by":"crossref","first-page":"778","DOI":"10.4049\/jimmunol.176.2.778","article-title":"Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death","volume":"176","author":"Stillman","year":"2006","journal-title":"J. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121378_bib17","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.ccr.2005.10.012","article-title":"TGF-\u03b2 directly targets cytotoxic T cell functions during tumor evasion of immune surveillance","volume":"8","author":"Thomas","year":"2005","journal-title":"Cancer Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib18","doi-asserted-by":"crossref","first-page":"4520","DOI":"10.1038\/s41467-020-18298-8","article-title":"Collagen promotes anti-PD-1\/PD-L1 resistance in cancer through LAIR1-dependent CD8+ T cell exhaustion","volume":"11","author":"Peng","year":"2020","journal-title":"Nat. Commun."},{"issue":"40","key":"10.1016\/j.biomaterials.2022.121378_bib19","doi-asserted-by":"crossref","first-page":"20141","DOI":"10.1073\/pnas.1901931116","article-title":"\u03b1v\u03b23-integrin regulates PD-L1 expression and is involved in cancer immune evasion","volume":"116","author":"Vannini","year":"2019","journal-title":"Proc. Natl. Acad. Sci. Unit. States Am."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib20","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ccell.2020.12.001","article-title":"Integrin \u03b1v\u03b26\u2013TGF\u03b2\u2013SOX4 pathway drives immune evasion in triple-negative breast cancer","volume":"39","author":"Bagati","year":"2021","journal-title":"Cancer Cell"},{"issue":"20","key":"10.1016\/j.biomaterials.2022.121378_bib21","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.122591","article-title":"Integrin \u03b1v\u03b28-expressing tumor cells evade host immunity by regulating TGF-\u03b2 activation in immune cells","volume":"3","author":"Takasaka","year":"2018","journal-title":"JCI Insight"},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121378_bib22","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/s41568-019-0116-x","article-title":"The evolving landscape of biomarkers for checkpoint inhibitor immunotherapy","volume":"19","author":"Havel","year":"2019","journal-title":"Nat. Rev. Cancer"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib23","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/s41523-019-0133-7","article-title":"If we build it they will come: targeting the immune response to breast cancer","volume":"5","author":"Gatti-Mays","year":"2019","journal-title":"npj Breast Canc."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib24","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121378_bib25","doi-asserted-by":"crossref","first-page":"R25","DOI":"10.1186\/gb-2010-11-3-r25","article-title":"A scaling normalization method for differential expression analysis of RNA-seq data","volume":"11","author":"Robinson","year":"2010","journal-title":"Genome Biol."},{"issue":"9","key":"10.1016\/j.biomaterials.2022.121378_bib26","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/nbt.2931","article-title":"Normalization of RNA-seq data using factor analysis of control genes or samples","volume":"32","author":"Risso","year":"2014","journal-title":"Nat. Biotechnol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nprot.2008.211","article-title":"Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources","volume":"4","author":"Huang da","year":"2009","journal-title":"Nat. Protoc."},{"key":"10.1016\/j.biomaterials.2022.121378_bib28","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1186\/1471-2105-10-73","article-title":"Disease candidate gene identification and prioritization using protein interaction networks","volume":"10","author":"Chen","year":"2009","journal-title":"BMC Bioinf."},{"issue":"W1","key":"10.1016\/j.biomaterials.2022.121378_bib29","doi-asserted-by":"crossref","first-page":"W199","DOI":"10.1093\/nar\/gkz401","article-title":"WebGestalt 2019: gene set analysis toolkit with revamped UIs and APIs","volume":"47","author":"Liao","year":"2019","journal-title":"Nucleic Acids Res."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib74","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/30.1.207","article-title":"Gene Expression Omnibus: NCBI gene expression and hybridization array data repository","volume":"30","author":"Edgar","year":"2002","journal-title":"Nucleic Acids Res."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121378_bib30","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/s41591-019-0404-8","article-title":"The landscape of cancer cell line metabolism","volume":"25","author":"Li","year":"2019","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121378_bib31","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12051307","article-title":"Single-cell transcriptomic analysis of tumor-derived fibroblasts and normal tissue-resident fibroblasts reveals fibroblast heterogeneity in breast cancer","volume":"12","author":"Sebastian","year":"2020","journal-title":"Cancers"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121378_bib32","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1053\/j.gastro.2020.11.044","article-title":"Cadherin 11 promotes immunosuppression and extracellular matrix deposition to support growth of pancreatic tumors and resistance to gemcitabine in mice","volume":"160","author":"Peran","year":"2021","journal-title":"Gastroenterology"},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121378_bib33","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: a portal for facilitating tumor subgroup gene expression and survival analyses","volume":"19","author":"Chandrashekar","year":"2017","journal-title":"Neoplasia"},{"key":"10.1016\/j.biomaterials.2022.121378_bib34","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1016\/j.csbj.2021.07.014","article-title":"Survival analysis across the entire transcriptome identifies biomarkers with the highest prognostic power in breast cancer","volume":"19","author":"Gy\u0151rffy","year":"2021","journal-title":"Comput. Struct. Biotechnol. J."},{"issue":"21","key":"10.1016\/j.biomaterials.2022.121378_bib35","doi-asserted-by":"crossref","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: a web server for comprehensive analysis of tumor-infiltrating immune cells","volume":"77","author":"Li","year":"2017","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.biomaterials.2022.121378_bib36","doi-asserted-by":"crossref","first-page":"4018","DOI":"10.1158\/1078-0432.CCR-19-3416","article-title":"The immunosuppressive Niche of soft-tissue sarcomas is sustained by tumor-associated macrophages and characterized by intratumoral tertiary lymphoid structures","volume":"26","author":"Chen","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.biomaterials.2022.121378_bib37","series-title":"The Jackson Laboratory Handbook on Genetically Standardized Mice","author":"Flurkey","year":"2009"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib38","doi-asserted-by":"crossref","first-page":"109","DOI":"10.5114\/ceji.2014.42135","article-title":"Perforin: an important player in immune response","volume":"39","author":"Osi\u0144ska","year":"2014","journal-title":"Cent. Eur. J. Immunol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121378_bib39","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/nmeth.3337","article-title":"Robust enumeration of cell subsets from tissue expression profiles","volume":"12","author":"Newman","year":"2015","journal-title":"Nat. Methods"},{"issue":"6230","key":"10.1016\/j.biomaterials.2022.121378_bib40","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1126\/science.aaa6204","article-title":"T cell exclusion, immune privilege, and the tumor microenvironment","volume":"348","author":"Joyce","year":"2015","journal-title":"Science"},{"issue":"7681","key":"10.1016\/j.biomaterials.2022.121378_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/nature24473","article-title":"A neoantigen fitness model predicts tumour response to checkpoint blockade immunotherapy","volume":"551","author":"\u0141uksza","year":"2017","journal-title":"Nature"},{"issue":"7681","key":"10.1016\/j.biomaterials.2022.121378_bib42","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/nature24462","article-title":"Identification of unique neoantigen qualities in long-term survivors of pancreatic cancer","volume":"551","author":"Balachandran","year":"2017","journal-title":"Nature"},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121378_bib43","first-page":"1561","article-title":"Demonstration of resistance against methylcholanthreneinduced sarcomas in the primary autochthonous host","volume":"20","author":"Klein","year":"1960","journal-title":"Cancer Res."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121378_bib44","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1001\/jamaoncol.2018.7147","article-title":"Current landscape of immunotherapy in breast cancer: a review","volume":"5","author":"Adams","year":"2019","journal-title":"JAMA Oncol."},{"issue":"10","key":"10.1016\/j.biomaterials.2022.121378_bib45","article-title":"Different culture media modulate growth, heterogeneity, and senescence in human mammary epithelial cell cultures","volume":"13","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2022.121378_bib46","article-title":"Mouse 4T1 breast tumor model","author":"Pulaski","year":"2001","journal-title":"Curr. Protoc. Immunol."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121378_bib47","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.cell.2016.12.022","article-title":"Systemic immunity is required for effective cancer immunotherapy","volume":"168","author":"Spitzer","year":"2017","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib48","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/s41392-020-00449-4","article-title":"Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy","volume":"6","author":"Tang","year":"2021","journal-title":"Sign. Transduct. Target. Ther."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121378_bib49","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1038\/nm.4123","article-title":"Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy","volume":"22","author":"Jiang","year":"2016","journal-title":"Nat. Med."},{"issue":"3","key":"10.1016\/j.biomaterials.2022.121378_bib50","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1158\/2159-8290.CD-17-0284","article-title":"Deconstruction of a metastatic tumor microenvironment reveals a common matrix response in human cancers","volume":"8","author":"Pearce","year":"2018","journal-title":"Cancer Discov."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib51","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/s41698-019-0087-0","article-title":"Pan-cancer analysis connects tumor matrisome to immune response","volume":"3","author":"Lim","year":"2019","journal-title":"npj Precision Oncol."},{"issue":"477","key":"10.1016\/j.biomaterials.2022.121378_bib52","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aat7973","article-title":"A biologic scaffold\u2013associated type 2 immune microenvironment inhibits tumor formation and synergizes with checkpoint immunotherapy","volume":"11","author":"Wolf","year":"2019","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.biomaterials.2022.121378_bib53","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.biomaterials.2018.11.002","article-title":"Divergent immune responses to synthetic and biological scaffolds","volume":"192","author":"Sadtler","year":"2019","journal-title":"Biomaterials"},{"issue":"11","key":"10.1016\/j.biomaterials.2022.121378_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0207255","article-title":"MMP-9 inhibition promotes anti-tumor immunity through disruption of biochemical and physical barriers to T-cell trafficking to tumors","volume":"13","author":"Juric","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/j.biomaterials.2022.121378_bib55","series-title":"ECM Components Guide IL-10 Producing Regulatory T-Cell (TR1) Induction from Effector Memory T-Cell Precursors","first-page":"201017360","author":"Bollyky","year":"2011"},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121378_bib56","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.4049\/jimmunol.177.6.3534","article-title":"Thrombospondin\/CD47 interaction: a pathway to generate regulatory T cells from human CD4+ CD25\u2212 T cells in response to inflammation","volume":"177","author":"Grimbert","year":"2006","journal-title":"J. Immunol."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121378_bib57","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1074\/jbc.M311183200","article-title":"Presentation of galectin-1 by extracellular matrix triggers T cell death","volume":"279","author":"He","year":"2004","journal-title":"J. Biol. Chem."},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121378_bib58","doi-asserted-by":"crossref","first-page":"C972","DOI":"10.1152\/ajpcell.00402.2014","article-title":"Secreted protein acidic and rich in cysteine facilitates age-related cardiac inflammation and macrophage M1 polarization","volume":"308","author":"Toba","year":"2015","journal-title":"Am. J. Physiol. Cell Physiol."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121378_bib59","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1084\/jem.20160831","article-title":"Integrin-targeted cancer immunotherapy elicits protective adaptive immune responses","volume":"214","author":"Kwan","year":"2017","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.biomaterials.2022.121378_bib60","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.matbio.2016.11.009","article-title":"Discoidin domain receptor 1 kinase activity is required for regulating collagen IV synthesis","volume":"57\u201358","author":"Borza","year":"2017","journal-title":"Matrix Biol."},{"issue":"8","key":"10.1016\/j.biomaterials.2022.121378_bib61","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1128\/MCB.21.8.2906-2917.2001","article-title":"Discoidin domain receptor 1 tyrosine kinase has an essential role in mammary gland development","volume":"21","author":"Vogel","year":"2001","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.biomaterials.2022.121378_bib62","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/jemt.20564","article-title":"Mammalian collagen IV","volume":"71","author":"Khoshnoodi","year":"2008","journal-title":"Microsc. Res. Tech."},{"issue":"338","key":"10.1016\/j.biomaterials.2022.121378_bib63","doi-asserted-by":"crossref","first-page":"ra76","DOI":"10.1126\/scisignal.2005347","article-title":"Type IV collagen is an activating ligand for the adhesion G protein-coupled receptor GPR126","volume":"7","author":"Paavola","year":"2014","journal-title":"Sci. Signal."},{"issue":"6377","key":"10.1016\/j.biomaterials.2022.121378_bib64","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1126\/science.aao1710","article-title":"A major chromatin regulator determines resistance of tumor cells to T cell\u2013mediated killing","volume":"359","author":"Pan","year":"2018","journal-title":"Science"},{"issue":"4","key":"10.1016\/j.biomaterials.2022.121378_bib65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0029587","article-title":"Tetrastatin, the NC1 domain of the \u03b14(IV) collagen chain: a novel potent anti-tumor Matrikine","volume":"7","author":"Brassart-Pasco","year":"2012","journal-title":"PLoS One"},{"issue":"12","key":"10.1016\/j.biomaterials.2022.121378_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0051044","article-title":"Arresten, a collagen-derived angiogenesis inhibitor, suppresses invasion of squamous cell carcinoma","volume":"7","author":"Aikio","year":"2012","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib67","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1471-2407-10-29","article-title":"Pentastatin-1, a collagen IV derived 20-mer peptide, suppresses tumor growth in a small cell lung cancer xenograft model","volume":"10","author":"Koskimaki","year":"2010","journal-title":"BMC Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121378_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jphs.2018.12.001","article-title":"A current perspective of canstatin, a fragment of type IV collagen alpha 2 chain","volume":"139","author":"Okada","year":"2019","journal-title":"J. Pharmacol. Sci."},{"issue":"7","key":"10.1016\/j.biomaterials.2022.121378_bib69","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.matbio.2005.07.004","article-title":"Type IV collagen induces STAT5 activation in MCF7 human breast cancer cells","volume":"24","author":"Robledo","year":"2005","journal-title":"Matrix Biol."},{"issue":"6","key":"10.1016\/j.biomaterials.2022.121378_bib70","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ncb2743","article-title":"The collagen receptor discoidin domain receptor 2 stabilizes SNAIL1 to facilitate breast cancer metastasis","volume":"15","author":"Zhang","year":"2013","journal-title":"Nat. Cell Biol."},{"issue":"1","key":"10.1016\/j.biomaterials.2022.121378_bib71","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/sj.bjc.6604443","article-title":"Collagen IV levels are elevated in the serum of patients with primary breast cancer compared to healthy volunteers","volume":"99","author":"Mazouni","year":"2008","journal-title":"Br. J. Cancer"},{"issue":"2","key":"10.1016\/j.biomaterials.2022.121378_bib72","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/bjc.1997.37","article-title":"Laminin and collagen IV subunit distribution in normal and neoplastic tissues of colorectum and breast","volume":"75","author":"Hewitt","year":"1997","journal-title":"Br. J. Cancer"},{"issue":"13","key":"10.1016\/j.biomaterials.2022.121378_bib73","doi-asserted-by":"crossref","first-page":"11020","DOI":"10.18632\/oncotarget.24280","article-title":"Selective targeting of collagen IV in the cancer cell microenvironment reduces tumor burden","volume":"9","author":"Revert","year":"2018","journal-title":"Oncotarget"}],"container-title":["Biomaterials"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222000175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0142961222000175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T17:06:36Z","timestamp":1758906396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0142961222000175"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":74,"alternative-id":["S0142961222000175"],"URL":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121378","relation":{},"ISSN":["0142-9612"],"issn-type":[{"value":"0142-9612","type":"print"}],"subject":[],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular matrix modulates T cell clearance of malignant cells in vitro","name":"articletitle","label":"Article Title"},{"value":"Biomaterials","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biomaterials.2022.121378","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"121378"}}